tuberous sclerosis

Showing 1 posts of 1 posts found.

FDA approves Novartis’ Afinitor

November 1, 2010
Sales and Marketing Afinitor, Novartis, subependymal giant cell astrocytomas, tuberous sclerosis

Novartis’ drug Afinitor has been approved by US authorities as a first line treatment for patients with benign brain tumours …

The Gateway to Local Adoption Series

Latest content